B

Bellerophon Therapeutics Inc
OTC:BLPH

Watchlist Manager
Bellerophon Therapeutics Inc
OTC:BLPH
Watchlist
Price: 0.1025 USD
Market Cap: 146.8k USD

Intrinsic Value

There is not enough data to reliably calculate the intrinsic value of BLPH.

The Intrinsic Value is calculated as the average of DCF and Relative values:

BLPH Intrinsic Value
Not Available
B
Base Case Scenario
Compare BLPH to

Fundamental Analysis

Bellerophon Therapeutics Inc
OTC:BLPH
US
Health Care
Market Cap
146.8k USD
IPO
Feb 13, 2015
US
Health Care
Market Cap
146.8k USD
IPO
Feb 13, 2015
Price
$
$
Company Overview
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about 6L7A?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Bellerophon Therapeutics Inc

Current Assets 5m
Cash & Short-Term Investments 4.4m
Other Current Assets 597k
Current Liabilities 1.3m
Accounts Payable 612k
Accrued Liabilities 644k
Efficiency

Free Cash Flow Analysis
Bellerophon Therapeutics Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Bellerophon Therapeutics Inc

Revenue
5.6m USD
Operating Expenses
-16.7m USD
Operating Income
-11m USD
Other Expenses
1.8m USD
Net Income
-9.3m USD
Fundamental Scores

BLPH Profitability Score
Profitability Due Diligence

Bellerophon Therapeutics Inc's profitability score is 45/100. The higher the profitability score, the more profitable the company is.

Exceptional 3Y Average ROIC
Exceptional ROIC
ROIC is Increasing
Low 3Y Average Gross Margin
45/100
Profitability
Score

Bellerophon Therapeutics Inc's profitability score is 45/100. The higher the profitability score, the more profitable the company is.

BLPH Solvency Score
Solvency Due Diligence

Bellerophon Therapeutics Inc's solvency score is 60/100. The higher the solvency score, the more solvent the company is.

Low D/E
Short-Term Solvency
Long-Term Solvency
Low Altman Z-Score
60/100
Solvency
Score

Bellerophon Therapeutics Inc's solvency score is 60/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

BLPH Price Targets Summary
Bellerophon Therapeutics Inc

There are no price targets for BLPH.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for 6L7A is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y